PV701

Known as: PV 701, PV-701 
An attenuated, replication-competent, oncolytic strain of Newcastle disease virus. PV701 selectively lyses tumor cells. The selectivity of this agent… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

2002-2008
0120022008

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
6. McKee, TD, Grandi, P, Mok, W, Alexandrakis, G, Insin, N, Zimmer, JP et al. (2006). Degradation of fi brillar collagen in a… (More)
Is this relevant?
2007
2007
PURPOSE Previous phase 1 trials of i.v.-administered PV701 have shown this virus to be well-tolerated with toxicity primarily… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
Is this relevant?
Review
2007
Review
2007
PV701 is a naturally-attenuated, non-recombinant, oncolytic strain of Newcastle disease virus that displays preclinical… (More)
Is this relevant?
Review
2007
Review
2007
We are very pleased and proud to be able to publish this special issue of Current Cancer Drug Targets devoted to oncolytic virus… (More)
Is this relevant?
2006
2006
PURPOSE In a previous phase 1 study, adverse events, especially flu-like symptoms, were observed mainly following the first i.v… (More)
Is this relevant?
2005
2005
Despite the best available agents to prevent mucositis, most patients receiving high-dose chemoradiotherapy regimens experience… (More)
Is this relevant?
2004
2004
3037 Background: PV701 is a non-recombinant, replication-competent Newcastle disease virus that targets tumor-specific defects in… (More)
Is this relevant?
Review
2003
Review
2003
PV701 is an attenuated, non-recombinant, oncolytic strain of Newcastle disease virus that displays preclinical intravenous (i.v… (More)
Is this relevant?
Highly Cited
2002
Highly Cited
2002
PURPOSE PV701, a replication-competent strain of Newcastle disease virus, causes regression of tumor xenografts after intravenous… (More)
Is this relevant?